Corporate partners
|
The SWEET project is supported by unrestricted grants from the following companies:
|
|||
|
|
Bayer HealthCare Diabetes Care supports customers in 100 countries. Since the introduction of Clinitest® reagent tablets in 1941, Bayer has led the way in diabetes care product innovation. The company changed the face of diabetes care in 1969 when it introduced the first portable blood glucose meter and test strips. Bayer HealthCare further innovated diabetes management by being the first company to introduce a suite of blood glucose monitors with No Coding™ technology. The BREEZE2® and CONTOUR® blood glucose monitoring systems offer people with diabetes an unparalleled choice in diabetes management systems.
|
||
|
|
|
||
|
|
DexCom, Inc., headquartered in California, is focused on pioneering innovative continuous glucose monitoring technologies to help people with diabetes and in the Intensive Care Unit of hospitals. The DexCom Seven System is approved for up to 7 days of continuous use, providing a current glucose value, 1-hr, 3-hr and 9-hr trending screens and customizable alerts to allow patients to take corrective actions regarding their glucose levels. | ||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
Lilly (www.lilly.com) is an innovation-driven pharmaceutical company with a long tradition in diabetes. We are developing a growing portfolio of innovative pharmaceutical products by applying research from our own worldwide laboratories, by collaborating with eminent scientific organizations, by making use of up-to-date technological tools, and by providing excellent service to our customers. Lilly Diabetes is committed to the success in the fight against diabetes by complementing therapeutic portfolio with non-pharmaceutical approaches. This commitment is exemplified by numerous programs focused on advancing the scientific and clinical understanding of diabetes and improving diabetes education and care. As a sign of Lilly´s commitment to diabetes, Diabetes Excellence Center (DEC) was established in Germany in 2007 to enhance diabetes prevention, awareness, education, research and patient care in Europe. DEC is also partnering with organizations such as SWEET to improve diabetes care in Europe.
|
||
|
|
|
||
|
|
Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology, alleviating pain, restoring health and extending life for millions of people around the world. Medtronic provides physicians and hospitals with products and therapies which each year contribute improve the life of more than 5 million patients. Medtronic’s European headquarter is in Tolochenaz (VD), Switzerland. The Diabetes division at Medtronic (www.medtronicdiabetes.com) is the world leader in advanced diabetes management solutions, including integrated diabetes management systems, insulin pump therapy, continuous glucose monitoring systems and therapy management software. For more information please visit www.medtronic.com and www.medtronic.eu. | ||
|
|
|
||
|
|
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,550 employees in 80 countries, and markets its products in 179 countries. For more information please visit www.novonordisk.com
|
||
|
|
|
||
|
|
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, the Accu-Chek brand has been committed to enable people with diabetes to live life as normal and active as possible as well as to help healthcare professionals manage their patient’s condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and services and comprehensive solutions for convenient, efficient and effective diabetes management spanning from blood glucose monitoring through information management to insulin delivery. The Accu-Chek brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information please visit www.accu-chek.com or www.roche.com. |
||
|
|
|
||
The SWEET members acknowledge the generous support.